Ind-Swift reports net loss of Rs 62.90 crore in Q1

29 Aug 2012 Evaluate

Ind-Swift has reported results for first quarter ended June 30, 2012.

On standalone basis, the company has reported a net loss of Rs 62.90 crore for the quarter ended June 30, 2012 against net profit of Rs 15.34 crore for the corresponding period last fiscal.  However, total income increased by 63.31% at Rs 392.66 crore during the quarter under review from Rs 240.43 crore in the year-ago period.

Ind-Swift is a fully integrated pharma group. The API required for the product was supplied from the USFDA and MHRA approved plant of Ind-Swif Laboratories and the formulations was manufactured and supplied from the 100% export facility of Ind-Swift located near Derabassi Punjab.

Ind-Swift - Amalgama Share Price

15.70 0.00 (0.00%)
13-Aug-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×